After losing 120 pounds, Jelly Roll shared a milestone he achieved on his weight loss journey at a pre-Super Bowl 2025 party.
Starting my journey on November 1 2023, I used Nutracheck’s app every single day to help track what I was eating. Eight ...
T-ara's Hyomin revealed her weight loss journey, successfully slimming down from 56 kg to 49 kg. She emphasized healthy ...
Pepsi's financial wellness partnership, the growing popularity of GLP-1 weight loss drugs and more top the list of core ...
Eli Lilly on Thursday suggested that demand for its popular diabetes and weight-loss treatments was not a concern, easing ...
Eli Lilly expects to provide results from a study in people with obesity and osteoarthritis of the knee in 2025.
Novo Nordisk has a dominant position in diabetes and weight-loss drugs, strong financial growth outlook, and great potential. Click to read why NVO is a Strong Buy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results